Wang Y, Han J, Yin S, Yang S, et al. Bruton's tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous system. Leuk Lymphoma 2025 Jan 17:1-10. doi: 10.1080/10428194.2025.2451066.
PMID: 39819306